Brazilian biotech foundation developing vaccines and immunobiologics for public health
Fundação Butantan operates a vertically integrated vaccine manufacturing and R&D organization anchored in SAP enterprise systems (S/4HANA, SuccessFactors, Ariba) across production, quality, and finance. The hiring acceleration is heavily skewed toward manufacturing and operations roles, with junior-level positions dominating — indicating aggressive scale-up of production capacity rather than R&D or commercial expansion. Active projects span dengue vaccine production, mRNA vaccine technology transfer, and operational process controls, paired with pain points around production optimization and post-market safety monitoring.
Fundação Butantan is a research and manufacturing foundation established in 1989 to support the Instituto Butantan's immunobiological development and production mandate under Brazil's Ministry of Health. The organization operates across vaccine research, manufacturing, quality assurance, and regulatory compliance, serving public health infrastructure at scale. Current production focus includes dengue vaccines and mRNA vaccine platforms, supported by tech infrastructure spanning SAP ERP systems, manufacturing controls (Siemens, Rockwell, Schneider Electric), and data management tools (REDCap, Minitab). The foundation employs between 1,001 and 5,000 people across São Paulo.
Core systems include SAP S/4HANA, SuccessFactors, and Ariba for enterprise resource planning; REDCap and Minitab for data analysis; Siemens, Rockwell Automation, and Schneider Electric for manufacturing controls; AutoCAD and CAD for design; and SSL/SAP Router for security.
Active projects include dengue vaccine production, mRNA vaccine technology transfer, new product development, operational procedure standardization, HVAC equipment qualification, academic management system implementation, and internal control frameworks focused on risk management.
Other companies in the same industry, closest in size